Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab in Chinese patients with advanced solid tumors
NCT02593786Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jan 2016
- Primary completion
- Sep 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in solid tumor, sponsored by Bristol Myers Squibb. Started Jan 2016; status: completed.
02
Drugs
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02593786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02593786.